StockData
ABSINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

Absci Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$8.54+0.29 (+3.52%)

Close on Oct 19, 2026

Market cap
$1.34B
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Nov 11, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 11, 2026After market close$300.00K––
Q1 FY2026
Ended Mar 31, 2026
May 7, 2026After market close$200.00K$-0.19–
Q4 FY2025
Ended Dec 31, 2025
Mar 24, 2026After market close$700.00K$-0.20–
Q3 FY2025
Ended Sep 30, 2025
Nov 12, 2025After market close$400.00K$-0.20–
Q2 FY2025
Ended Jun 30, 2025
Aug 12, 2025After market close$600.00K$-0.24–
Q1 FY2025
Ended Mar 31, 2025
May 13, 2025After market close$1.20M$-0.21–
Q4 FY2024
Ended Dec 31, 2024
Mar 18, 2025After market close$700.00K––
Q3 FY2024
Ended Sep 30, 2024
Nov 12, 2024Before market open$1.70M––
Q2 FY2024
Ended Jun 30, 2024
Aug 14, 2024After market close–––
Q1 FY2024
Ended Mar 31, 2024
May 14, 2024Before market open–––
Q4 FY2023
Ended Dec 31, 2023
Mar 21, 2024Before market open–––

Company guidance

Outlook given with results on Nov 12, 2024, compared with the previous outlook

MeasurePeriodGuidancevs. prior
gross use of cash, cash equivalents, and short-term investmentsfiscal year ending December 31, 2024$75.00MNew

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Absci filed with the SEC